Search Results - "Šišková, Lenka"

A haplotype constituted of four MMP-2 promoter polymorphisms (−1575G/A, −1306C/T, −790T/G and −735C/T) is associated with coronary triple-vessel disease by Vašků, Anna, Goldbergová, Monika, Izakovičová Hollá, Lydie, Šišková, Lenka, Groch, Ladislav, Beránek, Michal, Tschöplová, Svatava, Znojil, Vladimı́r, Vácha, Jiřı&#x0301

“…Vascular lesion development is associated with an accumulation of extracellular matrix proteins within the vessel wall. The proteins are degraded by matrix…”
Get full text

EMPIRE Registry, Czech Part: Impact of demographics, pulmonary function and HRCT on survival and clinical course in idiopathic pulmonary fibrosis by Doubková, Martina, Švancara, Jan, Svoboda, Michal, Šterclová, Martina, Bartoš, Vladimír, Plačková, Martina, Lacina, Ladislav, Žurková, Monika, Binková, Ilona, Bittenglová, Radka, Lošťáková, Vladimíra, Merta, Zdeněk, Šišková, Lenka, Tyl, Richard, Lisá, Pavlína, Šuldová, Hana, Petřík, František, Pšikalová, Jana, Řihák, Vladimír, Snížek, Tomáš, Reiterer, Pavel, Homolka, Jiří, Musilová, Pavlína, Lněnička, Jaroslav, Palúch, Peter, Hrdina, Roman, Králová, Renata, Hortvíková, Hana, Strenková, Jana, Vašáková, Martina

“…Prognostic factors of idiopathic pulmonary fibrosis (IPF) currently recognized include changes in vital capacity and radiologic findings. However, most of the…”
Get more information

The European MultiPartner IPF registry (EMPIRE): validating long-term prognostic factors in idiopathic pulmonary fibrosis by Tran, Tanja, Šterclová, Martina, Mogulkoc, Nesrin, Lewandowska, Katarzyna, Müller, Veronika, Hájková, Marta, Kramer, Mordechai R, Jovanović, Dragana, Tekavec-Trkanjec, Jasna, Studnicka, Michael, Stoeva, Natalia, Hejduk, Karel, Dušek, Ladislav, Suissa, Samy, Vašáková, Martina

“…Several registries of idiopathic pulmonary fibrosis (IPF) have been established to better understand its natural history, though their size and duration of…”
Get full text

Association of 3 gene polymorphisms with atopic diseases by Hollá, Lydie, Văsku̇, Anna, Znojil, Vladimír, S̆is̆ková, Lenka, Vácha, Jir̆í

“…Background: Various peptidases, including angiotensin-converting enzyme (ACE), inactivate some inflammatory peptides that are considered to influence the…”
Get full text

DSP rs2076295 variants influence nintedanib and pirfenidone outcomes in idiopathic pulmonary fibrosis: a pilot study by Doubkova, Martina, Kriegova, Eva, Littnerova, Simona, Schneiderova, Petra, Sterclova, Martina, Bartos, Vladimir, Plackova, Martina, Zurkova, Monika, Bittenglova, Radka, Lostaková, Vladimira, Siskova, Lenka, Lisa, Pavlina, Suldova, Hana, Doubek, Michael, Psikalova, Jana, Snizek, Tomas, Musilova, Pavlina, Vasakova, Martina

“…Background: The antifibrotic drugs nintedanib and pirfenidone are used for the treatment of idiopathic pulmonary fibrosis (IPF). We analysed the association of…”
Get full text

The C766T low-density lipoprotein receptor related protein polymorphism and coronary artery disease, plasma lipoproteins, and longevity in the Czech population by BENES, Petr, MUZIK, Jan, BENEDIK, Jaroslav, ELBL, Lubomir, VASKU, Anna, SISKOVA, Lenka, ZNOJIL, Vladimir, VACHA, Jiri

“…Low-density lipoprotein receptor related protein (LRP) is a multifunctional endocytic receptor involved in various biological processes including the…”
Get full text

Autologous dendritic cell-based immunotherapy (DCVAC/LuCa) and carboplatin/paclitaxel in advanced non-small cell lung cancer: A randomized, open-label, phase I/II trial by Zemanova, Milada, Cernovska, Marketa, Havel, Libor, Bartek, Tomas, Lukesova, Sarka, Jakesova, Jitka, Vanasek, Jaroslav, Reiterer, Pavel, Kultan, Juraj, Andrasina, Igor, Siskova, Lenka, Koubkova, Leona, Skrickova, Jana, Salajka, Frantisek, Pesek, Milos, Klepetko, Petr, Beniak, Juraj, Fricke, Harald, Kadlecova, Pavla, Korolkiewicz, Roman P., Hraska, Marek, Bartunkova, Jirina, Spisek, Radek

“…•Dendritic cell-based immunotherapy (DCVAC/LuCa) plus a platinum doublet in NSCLC.•SLU01: a multicenter, open-label, parallel-group, randomized, phase I/II…”
Get full text

Idiopathic pulmonary fibrosis prognostic factors - analysis of the Czech registry by Doubková, Martina, Uher, Michal, Bartoš, Vladimír, Šterclová, Martina, Lacina, Ladislav, Lošťáková, Vladimíra, Binková, Ilona, Plačková, Martina, Žurková, Monika, Bittenglová, Radka, Pšikalová, Jana, Šišková, Lenka, Lisá, Pavlína, Petřík, František, Polák, Jaroslav, Řihák, Vladimír, Skřičková, Jana, Vašáková, Martina

“…Idiopathic pulmonary fibrosis (IPF) is a rare, progressive and usually fatal form of idiopathic interstitial pneumonia. IPF is characterized by failure of…”
Get more information

rs2076295 variants influence nintedanib and pirfenidone outcomes in idiopathic pulmonary fibrosis: a pilot study by Martina Doubkova, Eva Kriegova, Simona Littnerova, Petra Schneiderova, Martina Sterclova, Vladimir Bartos, Martina Plackova, Monika Zurkova, Radka Bittenglova, Vladimira Lostaková, Lenka Siskova, Pavlina Lisa, Hana Suldova, Michael Doubek, Jana Psikalova, Tomas Snizek, Pavlina Musilova, Martina Vasakova

“…Background: The antifibrotic drugs nintedanib and pirfenidone are used for the treatment of idiopathic pulmonary fibrosis (IPF). We analysed the association of…”
Get full text